On ECHEMI
Home > Drugs > Sichuan Defeng Pharmaceutical Co., Ltd.
Sichuan Defeng Pharmaceutical Co., Ltd.
  • Founded in:

    1994-03-16
  • Country:

    China China
  • Address:

    No. 5 Xiangzhang Road, New District, Meishan Economic Development Zone
  • Tax NO.:

    91511402603654513P
  • Registered Funds:

    130 million yuan
  • Email:

Related Drugs
Trimethoprim-sulfamethoxazole tablets
This product is a compound preparation, each tablet contains sulfamethoxazole, sulfadiazine and trimethoprim
Name Description Content CAS NO. Registered Holders
sulfamethoxazole,SMZ

It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.

More

It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.

0
Sulfadiazine

It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfamethoxazole, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.

More

It competes with p-aminobenzoic acid for dihydrofolate synthase, inhibiting bacterial synthesis of dihydrofolate; when used in combination with trimethoprim and sulfamethoxazole, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains.

68-35-9 14
Trimethoprim

By inhibiting bacterial dihydrofolate reductase, it prevents dihydrofolate from being reduced to tetrahydrofolate; when used in combination with sulfamethoxazole and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains

More

By inhibiting bacterial dihydrofolate reductase, it prevents dihydrofolate from being reduced to tetrahydrofolate; when used in combination with sulfamethoxazole and sulfadiazine, it has a dual blocking effect on the bacterial synthesis of tetrahydrofolate, enhancing the antibacterial effect and reducing drug-resistant strains

738-70-5 44
Aspirin enteric-coated tablets
Aspirin. Chemical name: 2-(acetoxy)benzoic acid, molecular formula: C9H8O4, molecular weight: 180.2
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

①Analgesic effect: It is mainly through inhibiting the synthesis of prostaglandins and other substances that can make pain sensitive to mechanical or chemical stimulation (such as bradykinin, histamine), and it is a peripheral analgesic. However, the possibility of central analgesia (possibly acting on the hypothalamus) cannot be ruled out; ②Anti-inflammatory effect: The exact mechanism is still unclear. It may be due to the fact that this product acts on inflamed tissues and inhibits the synthesis of prostaglandins or other substances that can cause inflammatory reactions (such as histamine) to play an anti-inflammatory role. Inhibition of the release of lysosomal enzymes and leukocyte chemotaxis may also be related to it; ③Antipyretic effect: It may act on the hypothalamic thermoregulatory center to cause peripheral vasodilation, increased skin blood flow, sweating, and increased heat dissipation to play an antipyretic role. This central effect may be related to the inhibition of prostaglandin synthesis in the hypothalamus; ④Anti-rheumatic effect: The anti-rheumatic mechanism of this product, in addition to antipyretic and analgesic effects, is mainly anti-inflammatory; ⑤Inhibition of platelet aggregation: It works by inhibiting platelet cyclooxygenase and reducing the production of prostaglandins.

More

①Analgesic effect: It is mainly through inhibiting the synthesis of prostaglandins and other substances that can make pain sensitive to mechanical or chemical stimulation (such as bradykinin, histamine), and it is a peripheral analgesic. However, the possibility of central analgesia (possibly acting on the hypothalamus) cannot be ruled out; ②Anti-inflammatory effect: The exact mechanism is still unclear. It may be due to the fact that this product acts on inflamed tissues and inhibits the synthesis of prostaglandins or other substances that can cause inflammatory reactions (such as histamine) to play an anti-inflammatory role. Inhibition of the release of lysosomal enzymes and leukocyte chemotaxis may also be related to it; ③Antipyretic effect: It may act on the hypothalamic thermoregulatory center to cause peripheral vasodilation, increased skin blood flow, sweating, and increased heat dissipation to play an antipyretic role. This central effect may be related to the inhibition of prostaglandin synthesis in the hypothalamus; ④Anti-rheumatic effect: The anti-rheumatic mechanism of this product, in addition to antipyretic and analgesic effects, is mainly anti-inflammatory; ⑤Inhibition of platelet aggregation: It works by inhibiting platelet cyclooxygenase and reducing the production of prostaglandins.

50-78-2 35
Bifendate Tablets
Biphenyl diester. Chemical name: 4,4-dimethoxy-5,6,5,6-bis(methylenedioxy)biphenyl-2,2-dicarboxylic acid dimethyl ester. Molecular weight: 418.36 Molecular formula: C20H18O10
Name Description Content CAS NO. Registered Holders
Bifendate

This product is an intermediate in the synthesis of Schisandrae Chinensis A, which can reduce liver damage and alanine aminotransferase (ALT) elevation caused by carbon tetrachloride, inhibit liver microsomal lipid peroxidation caused by carbon tetrachloride, and carbon tetrachloride metabolic conversion to carbon monoxide, reduce the consumption of reduced coenzyme II and oxygen in the process of carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; it can reduce the increase of liver ALT induced by prednisone, and promote liver regeneration in mice with partial hepatectomy; it has a significant induction effect on cytochrome P450 enzyme activity, and enhances the detoxification ability of carbon tetrachloride and certain carcinogens; it has an effect on improving protein metabolism in some hepatitis patients, increasing albumin and reducing globulin. It has no negative conversion effect on HbsAg and HbeAg, and cannot shrink enlarged liver and spleen.

More

This product is an intermediate in the synthesis of Schisandrae Chinensis A, which can reduce liver damage and alanine aminotransferase (ALT) elevation caused by carbon tetrachloride, inhibit liver microsomal lipid peroxidation caused by carbon tetrachloride, and carbon tetrachloride metabolic conversion to carbon monoxide, reduce the consumption of reduced coenzyme II and oxygen in the process of carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; it can reduce the increase of liver ALT induced by prednisone, and promote liver regeneration in mice with partial hepatectomy; it has a significant induction effect on cytochrome P450 enzyme activity, and enhances the detoxification ability of carbon tetrachloride and certain carcinogens; it has an effect on improving protein metabolism in some hepatitis patients, increasing albumin and reducing globulin. It has no negative conversion effect on HbsAg and HbeAg, and cannot shrink enlarged liver and spleen.

73536-69-3 12
Aben tablets
Each tablet of this product contains 0.1g of aspirin and 10mg of phenobarbital. The auxiliary material is starch.
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

0.1g 50-78-2 35
Phenobarbital

10mg 0
Starch

9005-25-8 78
Sugary pepsin
The main ingredients of this product are: proteolytic enzymes extracted from the gastric mucosa of pigs, sheep or cattle. This product is made by diluting pepsin with lactose, glucose or sucrose. The protease activity contained in each 1g shall not be less than 120 units or 1200 units.
Name Description Content CAS NO. Registered Holders
Pepsin

White or light yellow powder; sweet taste, no moldy smell; hygroscopic; aqueous solution has acidic reaction

More

White or light yellow powder; sweet taste, no moldy smell; hygroscopic; aqueous solution has acidic reaction

120 or 1200Unit/g 9001-75-6 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.